{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:33:27Z","timestamp":1765370007686,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.lfs.2022.120542","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:06:03Z","timestamp":1649192763000},"page":"120542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of insulin and sitagliptin on early cardiac dysfunction in diabetic rats"],"prefix":"10.1016","volume":"299","author":[{"given":"Walaa","family":"Wadie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehad S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani N.","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9785","key":"10.1016\/j.lfs.2022.120542_bb1000","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.lfs.2022.120542_bb1100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurheartj\/ehn062","article-title":"Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and\/or left ventricular dysfunction: a VALIANT study","volume":"29","author":"Lewis","year":"2008","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.lfs.2022.120542_bb1200","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","article-title":"Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study","volume":"30","author":"Du","year":"2009","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120542_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.lfs.2022.120542_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"10.1016\/j.lfs.2022.120542_bb0015","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ddmec.2010.08.001","article-title":"Diabetic cardiomyopathy: mechanisms and therapeutic targets","volume":"7","author":"Battiprolu","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.lfs.2022.120542_bb0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/CRD.0b013e318123f771","article-title":"Sitagliptin: a novel drug for the treatment of type 2 diabetes","volume":"15","author":"Choy","year":"2007","journal-title":"Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2022.120542_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijcard.2012.01.011","article-title":"Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia\u2013reperfusion injury","volume":"167","author":"Chinda","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.lfs.2022.120542_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078330","article-title":"Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily 27 by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms","volume":"8","author":"Picatoste","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.lfs.2022.120542_bb1300","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.pharep.2018.02.010","article-title":"Involvement of brain natriuretic peptide signaling pathway in the cardioprotective action of sitagliptin","volume":"70","author":"Abbas","year":"2018","journal-title":"Pharmacol. Rep. PR"},{"issue":"3","key":"10.1016\/j.lfs.2022.120542_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab. Anim."},{"issue":"9\u201310","key":"10.1016\/j.lfs.2022.120542_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"6","key":"10.1016\/j.lfs.2022.120542_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156346","article-title":"Short-and longterm glycemic control of streptozotocin-induced diabetic rats using different insulin preparations","volume":"11","author":"Luippold","year":"2016","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.lfs.2022.120542_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7150\/ijms.14141","article-title":"Role of serum biomarkers in early detection of diabetic cardiomyopathy in the west virginian population","volume":"13","author":"Shaver","year":"2016","journal-title":"Int. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.120542_bb1400","first-page":"498","article-title":"Biostatistics 103: qualitative data - tests of independence","volume":"44","author":"Chan","year":"2003","journal-title":"Singapore Med. J."},{"issue":"8","key":"10.1016\/j.lfs.2022.120542_bb1500","first-page":"354","article-title":"Biostatistics 301. Repeated measurement analysis","volume":"45","author":"Chan","year":"2004","journal-title":"Singapore Med. J."},{"issue":"3","key":"10.1016\/j.lfs.2022.120542_bb0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3892\/etm.2015.2211","article-title":"Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt\/GSK-3beta signaling pathway","volume":"9","author":"Liu","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.lfs.2022.120542_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1043-6618(03)00191-9","article-title":"Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats","volume":"48","author":"Akula","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120542_bb2000","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-017-0657-9","article-title":"Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus","volume":"17","author":"Gimenes","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120542_bb0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1248\/jhs.50.356","article-title":"Cardiac functional analysis by electrocardiography, echocardiography and in situ hemodynamics in streptozotocin-induced diabetic mice","volume":"50","author":"Li","year":"2004","journal-title":"J. Health Sci."},{"issue":"7","key":"10.1016\/j.lfs.2022.120542_bb1600","doi-asserted-by":"crossref","first-page":"e22777","DOI":"10.1371\/journal.pone.0022777","article-title":"3\u2019,4\u2019-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats","volume":"6","author":"Khong","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.lfs.2022.120542_bb1700","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ijmm.2013.1368","article-title":"Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis","volume":"32","author":"Becher","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.lfs.2022.120542_bb1800","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1042\/CS20160491","article-title":"Are targeted therapies for diabetic cardiomyopathy on the horizon?","volume":"131","author":"Tate","year":"2017","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120542_bb1900","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0000000000000504","article-title":"Resveratrol Ameliorates Cardiac Dysfunction by Inhibiting Apoptosis via the PI3K\/Akt\/FoxO3a Pathway in a Rat Model of Diabetic Cardiomyopathy","volume":"70","author":"Wu","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120542_bb2100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor necrosis factor-\u03b1 in heart failure: an updated review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"year":"2015","series-title":"Updating Experimental Models of Diabetic Cardiomyopathy","author":"Fuentes-Antr\u00e1s","key":"10.1016\/j.lfs.2022.120542_bb0070"},{"issue":"1","key":"10.1016\/j.lfs.2022.120542_bb2200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-016-2767-1","article-title":"Cardioprotective effects of rutin via alteration in TNF-\u03b1, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats","volume":"420","author":"Saklani","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2022.120542_bb2300","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/cvr\/cvx012","article-title":"Inflammation and metabolic cardiomyopathy","volume":"113","author":"Nishida","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2022.120542_bb2400","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/1753-0407.12538","article-title":"Cardioprotective effects of pectin\u2013insulin patch in streptozotocin-induced diabetic rats","volume":"9","author":"Sibiya","year":"2017","journal-title":"J. Diabetes"},{"issue":"11","key":"10.1016\/j.lfs.2022.120542_bb3000","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00125-016-4070-9","article-title":"MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice","volume":"59","author":"Zhang","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2022.120542_bb3100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/424813","article-title":"Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis","author":"Kelleni","year":"2015","journal-title":"J. Toxicol."},{"key":"10.1016\/j.lfs.2022.120542_bb3200","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/DDDT.S109287","article-title":"Sitagliptin attenuates cardiomyopathy by modulating the JAK\/STAT signaling pathway in experimental diabetic rats","volume":"10","author":"Al-Rasheed","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"6S","key":"10.1016\/j.lfs.2022.120542_bb3300","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.amjmed.2017.04.008","article-title":"Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes","volume":"130","author":"Paneni","year":"2017","journal-title":"Am. J. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:58:34Z","timestamp":1758401914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"alternative-id":["S0024320522002429"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120542","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of insulin and sitagliptin on early cardiac dysfunction in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120542"}}